A new Cuban vaccine against chronic hepatitis B, created by the Center for Genetic Engineering and Biotechnology (CIGB by its Spanish acronym), is currently undergoing clinical evaluation in eight countries, developed in collaboration with the French company Abivax, official media reported today.
Read More